期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

儿童肾病综合征免疫抑制剂的应用 被引量：1

下载PDF
导出
摘要 近年来,不断有应用激素以外的免疫抑制剂治疗肾病综合征,旨在控制激素耐药患儿的病情,改善并巩固激素治疗的效果,减少复发.有多种抗排斥反应的免疫抑制剂用来治疗激素耐药的肾病患者取得了显著疗效.
作者 邹敏书 余健 何威逊
机构地区 广州军区武汉总医院
出处 《华南国防医学杂志》 CAS 2005年第1期41-44,共4页 Military Medical Journal of South China
关键词 免疫抑制剂 肾病综合征 儿童 激素耐药 抗排斥反应 激素治疗 减少复发 肾病患者
分类号 R979.5 [医药卫生—药品] R692 [医药卫生—泌尿科学]
  • 相关文献

参考文献17

  • 1[1]Mosca M, Neri R, Giannessi S, et al. Therapy With pulse methylprednisolone and short course pulse cyclophosphamide for diffuse proliferative glomerulonephritis. Lupus, 2001,10(4): 253～ 257
  • 2[2]Cameron JS. Lupus nephritis. J Am Soc Nephrol, 1999, 10 (6):833 ～ 839
  • 3[3]Inone Y,Jimak Z, Nakamura H, et al .Two- year cyclosprin treatment in children With steroid- dependent nephrotic syndrome. Pediatr Nephrol, 1999,13(2) :33 ～ 38
  • 4[4]Bruatti S, Szer ZS, Spencer CH, et al . Mycoplenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus. J Rheumatol,2001,28(9):2103 ～ 2108
  • 5[5]Briggs WA, Choi MU, Scheel PJ. Successful mycophenolate mofetil treatment of glomerular disease. Am J Kidney, 1998,31(8) :213
  • 6[6]Chan TM, Li FK, Tang CS, et al . Efficacy of mycophenolate mofetil in patients With diffuse proliferative lupus nephritis.HongKong- GuangZhou Nephrology study Group. N Engl J Med,2000,343(11): 1156 ～ 1162
  • 7[7]Haubitz M, De- Groot K. Tolerance of mycophenolate mofetil in end- stage renal disease patient with ANCA- associated vasculitis. Clin Nephrol, 2002,57(6) :421 ～ 424
  • 8[8]Entani C,Izumino K, Iida H, et al .Effect of a novel immunosuppressant, FK506, on spontaneous lupus nephritis in MRL MPJ-lpr/lpr mice. Nephron, 1993,64(3) :471～ 475
  • 9[9]Handwick IL, Batick TD. Severe prolonged tacrolimus overdose with minimal consequences, pharmacotherapy, 2002, 22 (8):1063～ 1066
  • 10[10]Kaneko K, Nagaoka R, Ontomo Y, et al . Effect of MZR on IL6 release by peripheral blood monomuclear Cells. Nephron,2002,91(3) :506 ～ 508

同被引文献31

  • 1吴小川,易著文.联合免疫抑制剂治疗儿童难治性肾病综合征[J].实用儿科临床杂志,2006,21(17):1121-1122. 被引量：6
  • 2Koskimies O,Vilska J,Rapola J,et al.Long-term outcome of primary nephrotic syndrome[J].Arch Dis Child,1982,57(7):544-548.
  • 3Tarshish P,Tobin JN,Bernstein J,et al.Prognostic significance of the early course of minimal change nephrotic syndrome:report of the International Study of Kidney Disease in Children[J].J Am Soc Nephrol,1997,8(5):769-776.
  • 4Zagozdzon I,Zurowska A,Prokurat S,et al.Do children with end-stage renal disease live shorter?Analysis of mortality on the basis of data from the Polish Registry of Renal Replacement Therapy in Children[J].Adv Med Sci,2014,60(1):13-17.
  • 5Lombel RM,Gipson D,Sand Hodson EM.Treatment of steroid-sensitive nephrotic syndrome:new guidelines from KDIGO[J].Pediatr Nephrol,2013,28(3):415-426.
  • 6Greenbaum LA,Benndorf R,Smoyer WE.Childhood nephrotic syndrome--current and future therapies[J].Nat Rev Nephrol,2012,8(8):445-458.
  • 7Ishikura K,Yoshikawa N,Nakazato H,et al.Two-year follow-up of a prospective clinical trial of cyclosporine for frequently relapsing nephrotic syndrome in children[J].Clin J Am Soc Nephrol,2012,7(10):1576-1583.
  • 8Pravitsitthikul N,Willis NS,Hodson EM,et al.Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children[J].Cochrane Database Syst Rev,2013,10:Cd002290.
  • 9Ito S,Ikeda H,Harada T,et al.Cyclophosphamide followed by mizoribine as maintenance therapy against refractory steroid-dependent nephrotic syndrome[J].Pediatr Nephrol,2011,26(10):1921-1922.
  • 10Cattran DC,Alexopoulos E,Heering P,et al.Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome:workshop recommendations[J].Kidney Int,2007,72(12):1429-1447.

引证文献1

二级引证文献5

华南国防医学杂志
2005年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部